2022
DOI: 10.1007/s11940-022-00718-3
|View full text |Cite
|
Sign up to set email alerts
|

Toxic Myopathies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 114 publications
0
1
0
Order By: Relevance
“…There have been no previous reports of corticosteroid or disease-modifying-antirheumatic-drugs use in the treatment of isotretinoin-induced myositis [ 3 ]. In selected cases of drug-induced myopathies, such as following statin exposure, removal of causative medication has been noted to be insufficient, requiring the use of immunosuppression [ 9 ].…”
Section: Discussionmentioning
confidence: 99%
“…There have been no previous reports of corticosteroid or disease-modifying-antirheumatic-drugs use in the treatment of isotretinoin-induced myositis [ 3 ]. In selected cases of drug-induced myopathies, such as following statin exposure, removal of causative medication has been noted to be insufficient, requiring the use of immunosuppression [ 9 ].…”
Section: Discussionmentioning
confidence: 99%